SlideShare a Scribd company logo
1 of 49
Presented by:
DR. NABEEL S. BONDAGJI
DEFINITIONS:
a) Low birth weight (LBW)
b) Very low birth weight (VLBW)
c) Extremely low birth weight (ELBW)
d) Premature
e) Small for Gestational Age (SGA)
f) Large for Gestational Age (AGA)
g) Intrauterine Growth Retardation (IUGR)
SGA = IUGR = SFD
Incidence of SGA:
By definition, babies with BW < 10th
centile on growth curves are SGA.
Therefore, 10% of babies are SGA.
However, not as simple as this.
1. Sex: Male infants are 150 grams heavier
and o.0 cm. longer than female infants.
2. Parity: First born infants tend to be
smaller than infants born subsequently;
this effect dissipates after the third birth.
3. Racial and ethnic groups and
nationalities have differing normal birth
weights.
4. Altitude: In USA for example, growth
curves based on the Denver population located
approximately 5000 feet above sea level tend to
underestimate infants' weights after 32 weeks'
gestation.
5. Maternal size: direct association between
maternal height and weight and the size of the
fetus is well established. Birth weight variation
of 750 g between infants born to mothers of 170
cm in height and 75 kg weight when compared
with infants born to mothers 150 cm tall and
weighing 40 kg has been described.
6. Number of fetuses: mean birth
weight decreases with the number of
fetuses.
? Need for different growth curves to
take the above into account.
The overall perinatal mortality in IUGR
infants is increased eight- to ten-fold
that of AGA infants.
Higher risk of developmental problems
in SGA infants.
Fetal growth occurs in 3 phases.
1. 4-20 weeks' gestation – rapid cellular
development with mitosis
2. 20-28 weeks – increase in cellular size
combined with ongoing mitosis.
3. 28-40 weeks – cells rapidly increasing
in size, with peak at 33 weeks. In
addition, rapid accumulation of fat,
muscle and connective tissue occurs.
• Growth inhibition during stage II and
III will cause a decrease of cell size and
fetal weight with less effect on total cell
number and fetal length and head
circumference, causing asymmetric
IUGR.
Conditions associated with symmetric
IUGR:
• Genetic - constitutional, chromosomal and
single gene defects, and deletion disorders
and inborn errors of metabolism.
• Congenital anomalies,
• Intrauterine infections
• Others: substance abuse, cigarette smoking
and therapeutic irradiation.
Conditions associated with
asymmetric IUGR:
Uteroplacental insufficiency
- chronic hypertension,
- preeclampsia,
- placental infarcts
- abruptio placenta
- velamentous insertion of the
umbilical cord and circumvallate
placenta
Maternal illnesses
- chronic renal disease,
- cyanotic heart disease,
- hemoglobinopathies
- substance abuse and cigarette
smoking.
Other factors
- multiple gestation
- altitude
• Under conditions of stress (eg. Hypoxia)
– fetus mounts response with increased
Adr and NorAdr (found in amniotic
fluid) – leads to anti-insulin effect.
• In addition, this results in loss of fat,
muscle and glycogen with changes in
blood flow distribution to ‘vital organs’
(brain, heart and adrenal) – asymmetric.
Smoking, substance abuse and SGA.
- The mean birth weight is reduced by 175-
200 g in infants born to cigarette smokers
- Cotinine decreases uteroplacental blood
flow in a dose-related way by stimulating
sympathetic neurons.
- Carboxyhemoglobin levels are elevated in
mothers who smoke and in their fetuses, and
the avidity of fetal hemoglobin to carbon
monoxide may exacerbate fetal hypoxia.
- Nicotine has a demonstrated teratogenic
effect in animals.
- Marijuana, cocaine, heroin, amphetamines
and alcohol can all cause IUGR, with the
head circumference affected in many
studies, suggesting a symmetrical form of
growth retardation and an insult during the
cell mitotic phase in early pregnancy.
Prenatal Diagnosis:
1. Maternal history: e.g. pregnancy-
induced-hypertension.
2. Maternal examination - measurement of
fundal height is an excellent screening
tool for IUGR. 95% sensitivity.
- If fundal height is 4 cm less than
expected - ?SGA. Fundal height in cms
should equal gestation at 20 to 25 weeks.
3. Fetal ultrasound: BPD and AC measured.
- BPD (biparietal diam) 43-100% accurate
but inaccuracy due to head-sparing in
asymmetric IUGR.
- AC (Abdominal circumference better
sensitivity than that of cephalometry for
IUGR detection.
- HC/AC (Head circumference/abdominal
circumference ratio) is an important
measurement for detection of asymmetric
IUGR infants.
- Ratio of femoral length to abdominal
circumference (FL/AC) provides also an
accurate prediction of IUGR.
4. Amniotic fluid volume: oligohydramnios
due to decreased renal blood flow and
urine output.
5. Blood flow measurements: by Doppler
flow studies, fetal and uterine blood flow
can be measured and therefore
uteroplacental circulation dysfunctions
can be assessed.
6. Biochemical data:
a. Estriol: low 24 hours urinary estriol
excretion is associated with 21% of
IUGR infants.
b. Human placental lactogen (HPL).
Prenatal Management
- Symmetric IUGR – need to consider
amniocentesis and TORCH analysis, along
with Maternal TORCH antibody titres.
- Also need to look at Maternal Health – e.g.
illness such as chronic renal disease need to
be considered. This includes discouraging
tobacco use, and substance abuse as well as
regular checks through pregnancy
- Ongoing close observations, with U/S
(including doppler flows) and CTG’s.
- Early delivery has to be considered based
upon the relative chance of fetal morbidity
and mortality in-utero to the chance of
morbidity and mortality of prematurity. Can
often be a difficult choice.
Postnatal Management of SGA baby:
These babies handle stress of birth and post-natal
life poorly.
• Greater risk of stillbirth (4x)
• Greater risk of asphyxia (2x)
• Likely to have lower APGAR scores
• Higher incidence of meconium at delivery
• Risk of hypoglycaemia
• Risk of hypocalcaemia and hypomagnesaemia
• Risk of hypothermia
* Note, risk of lung disease is less than with AGA
babies as long as they get through birth OK.
At delivery:
- IUGR infants are more prone to
hypoxemia during labor and delivery
because of uteroplacental insufficiency, and
more prone to cord compression due to lack
of amniotic fluid and a thin cord.
- A neonatal team capable of managing
asphyxia and meconium aspiration
syndrome should be available at the time
of delivery.
- Special attention should be addressed to
prevention of hypothermia and
hypoglycemia.
Physical findings:
- Obviously, < 10th centile for gestation.
- Look at baby carefully – especially if
symmetrically growth retarded.
- Need to be wary of genetic/infective
causes – look for dysmorphic features, for
skin rashes (blueberry muffin and
patechiae) and for hepatosplenomegaly
- wisened old man appearance
- lack of subcutaneous fat
- skin is dry cracked and peeling
(especially palms & soles)
- often thin cord due to lack of Wharton’s
jelly
- may be meconium stained
- ruddy appearance due to polycythaemia
- may be jittery due to low sugar or calcium
- may also be irritable and show signs of
asphyxia, including fitting.
Attempt to identify the cause of IUGR:
Aetiologies:
a. Vascular diseases of the mother
(hypertension, renal disease, diabetes,
etc.) - 35%.
b. Chromosomal and other congenital
anomalies of the infant - 10%.
c. Normal variations (low maternal
weight/height, high altitude, multiple
gestation) - 10%.
d. Congenital infection - 5%.
e. Alcohol, smoking, substance abuse, and
medications (antimetabolites for cancer
therapy, hydantoin and trimethadion for
anticonvulsant therapy) - 5%.
f. Placenta and cord defects - 2%.
g. Uterine abnormalities - 1%.
h. Other: Therapeutic radiation, low
socioeconomic level and unknown
causes - 32%.
* Careful history and examination can identify
most causations.
Management after birth:
SGA babies are at risk as noted. Therefore
attention to WARM, PINK, SWEET &
INFECTION needed.
Need to attend to basics of care – in particular:
1. Respiratory care – esp. with meconium
2. Hypoglycaemia due to low sugar
reserves and higher energy consumption – esp.
with cold stress.
3. Hypothermia due to lack of
subcutaneous
fat and relatively high S.A to body
weight
ratio
4. Beware infection – at risk as immune
system of babies is immature – being
SGA worsens this.
5. Polycythaemia – due to in-utero hypoxia.
Can cause venous thrombo-emboli and
can also worsen cerebral ischaemia and
perpetuate hypoglycaemia.
6. Haemorrhage – can develop due to lack
of
liver coag factor production, and also
may
have low platelets if TORCH
7. Management of asphyxia
Investigations of SGA baby:
Initially, babies need to be examined in a
warm environment.
True blood glucose should be assessed at ½
to 1 hour of age, and pre-feeds for at least the
next 2 feeds. Feeds should be frequent (2-3
hourly initially).
If baby jittery, then glucose and calcium
and magnesium must be checked.
Full blood count - 3 reasons
- polycythaemia
- platelet count
- white cells
Other investigations done on merit
- chromosomes
- TORCH screen
- CXR if respiratory distress
- Sepsis workup if possibility of infection -
- Urine drug screen, etc., if suspect
maternal substance abuse
- Cranial US – esp. if concerned about
in-utero hypoxia
Nutrition:
- Important to establish nutrition as early as
possible but be wary as hypoxia and
polycythaemia may have resulted in
diminished gut blood flow – risk of NEC.
- If delay in establishing enteral feeds, must
use TPN.
- Weight gain monitoring needed to ensure
sufficiency of caloric intake.
- It is common that caloric intake in IUGR
infants will exceed the usual intake of 100-
120 Kcal/kg/day, and daily weight gain will
exceed 25 g/day.
- Neurologic prognosis may relate directly to
restoring good nutrition. Poor subsequent
head growth bodes poorly for intellectual
development.
DON’T FORGET THE PARENTS!!!
 Parental counselling about diagnosis,
risk for physical and developmental
sequelae, and risk of IUGR in a
subsequent pregnancy, should be
provided
Outcome for SGA babies:
Increased mortality and morbidity as noted.
Long term outlook:
Neurological.
- IUGR infants have an increased risk of
long-term neurologic and behavioral
handicaps. Infants with ultrasonographic
evidence of delayed head growth before the
third trimester also have delayed neurologic
and intellectual development.
- If congenital anomalies and clinically
detected prenatal infections are excluded,
studies show normal IQ/DQ in most SGA
infants.
- Preterm IUGR infants have similar outcomes
at
18-24 months of age, compared to AGA
preterm
infants.
- Severe malnutrition in utero can decrease the
number of brain cells. Normally in the first 2
years of life there occurs a "spurt in brain
- Overall, IUGR infants have an increased
incidence of lower intelligence, learning
and behavioral disorders and neurologic
handicaps.
- The long-term neurologic outcome in SGA
infants is related to the type of SGA,
severity and concomitant asphyxial insult.
- Future handicap is dependent also on the
existence of perinatal complications such as
asphyxia, meconium aspiration syndrome,
hypothermia, hypoglycemia and
polycythemia.
Growth.
- Asymmetric IUGR infants have better growth
potential than symmetric IUGR infants who
typically have suffered a genetic, infectious
or teratogenic insult early in life.
- Asymmetric SGA infants capable of
achieving normal weight and proportions
within 6-12 months of birth.
- Symmetric SGA infants born often remain
shorter, lighter and have a smaller head
circumference throughout life.
Other.
- Delayed eruption of teeth and enamel
hypoplasia.
- Increased incidence of postnatal
infections
possibly due to delayed humoral and
cellular immunity found .
- Risk of SIDS considerably greater (30% of
SIDS cases occur in SGA infants) – reasons
behind SGA may account for this however.
IUGR-Intrauterine Growth Retardation.ppt

More Related Content

Similar to IUGR-Intrauterine Growth Retardation.ppt

Fetal Growth Restriction.pptx
Fetal Growth Restriction.pptxFetal Growth Restriction.pptx
Fetal Growth Restriction.pptxAnchal265129
 
Intrauterine growth restriction (IUGR).pptx
Intrauterine growth restriction (IUGR).pptxIntrauterine growth restriction (IUGR).pptx
Intrauterine growth restriction (IUGR).pptxAnju Kumawat
 
IUGR (intra uterine growth restrictions )
IUGR (intra uterine growth restrictions )IUGR (intra uterine growth restrictions )
IUGR (intra uterine growth restrictions )Sujata Bhardwaj
 
LOW BIRTH WEIGHT BABY
LOW BIRTH WEIGHT BABYLOW BIRTH WEIGHT BABY
LOW BIRTH WEIGHT BABYSachin Gadade
 
Q3 LOW BIRTH BABY SLIDESHARE.pdf
Q3 LOW BIRTH BABY SLIDESHARE.pdfQ3 LOW BIRTH BABY SLIDESHARE.pdf
Q3 LOW BIRTH BABY SLIDESHARE.pdfprashant513130
 
Fetal Growth Restriction.pptx
Fetal Growth Restriction.pptxFetal Growth Restriction.pptx
Fetal Growth Restriction.pptxRAHULSUTHAR46
 
vdocuments.mx_iugr-newedited.ppt
vdocuments.mx_iugr-newedited.pptvdocuments.mx_iugr-newedited.ppt
vdocuments.mx_iugr-newedited.pptSrik58
 
Radiology 5th year, 8th & 9th lectures (Dr. Nasrin Alatrushi)
Radiology 5th year, 8th & 9th lectures (Dr. Nasrin Alatrushi)Radiology 5th year, 8th & 9th lectures (Dr. Nasrin Alatrushi)
Radiology 5th year, 8th & 9th lectures (Dr. Nasrin Alatrushi)College of Medicine, Sulaymaniyah
 
Zoltan Veresh - Intrauterine growth retardation
Zoltan Veresh - Intrauterine growth retardationZoltan Veresh - Intrauterine growth retardation
Zoltan Veresh - Intrauterine growth retardationKatalin Cseh
 
Approach to Intrauterine growth restriction
Approach to Intrauterine growth restrictionApproach to Intrauterine growth restriction
Approach to Intrauterine growth restrictionDr. Habibur Rahim
 
Obesity: A Pediatric Epidemic
Obesity: A Pediatric EpidemicObesity: A Pediatric Epidemic
Obesity: A Pediatric EpidemicDr.Mahmoud Abbas
 
Module 4 Paediatric Nutrition.pptx
Module 4 Paediatric Nutrition.pptxModule 4 Paediatric Nutrition.pptx
Module 4 Paediatric Nutrition.pptxShafaatHussain20
 

Similar to IUGR-Intrauterine Growth Retardation.ppt (20)

IUGR.pptx
IUGR.pptxIUGR.pptx
IUGR.pptx
 
IUGR PPT.pptx
IUGR PPT.pptxIUGR PPT.pptx
IUGR PPT.pptx
 
Fetal Growth Restriction.pptx
Fetal Growth Restriction.pptxFetal Growth Restriction.pptx
Fetal Growth Restriction.pptx
 
Iugr
IugrIugr
Iugr
 
Intrauterine growth restriction (IUGR).pptx
Intrauterine growth restriction (IUGR).pptxIntrauterine growth restriction (IUGR).pptx
Intrauterine growth restriction (IUGR).pptx
 
IUGR
IUGRIUGR
IUGR
 
IUGR.pptx
IUGR.pptxIUGR.pptx
IUGR.pptx
 
IUGR (intra uterine growth restrictions )
IUGR (intra uterine growth restrictions )IUGR (intra uterine growth restrictions )
IUGR (intra uterine growth restrictions )
 
LOW BIRTH WEIGHT BABY
LOW BIRTH WEIGHT BABYLOW BIRTH WEIGHT BABY
LOW BIRTH WEIGHT BABY
 
Q3 LOW BIRTH BABY SLIDESHARE.pdf
Q3 LOW BIRTH BABY SLIDESHARE.pdfQ3 LOW BIRTH BABY SLIDESHARE.pdf
Q3 LOW BIRTH BABY SLIDESHARE.pdf
 
Fetal Growth Restriction.pptx
Fetal Growth Restriction.pptxFetal Growth Restriction.pptx
Fetal Growth Restriction.pptx
 
vdocuments.mx_iugr-newedited.ppt
vdocuments.mx_iugr-newedited.pptvdocuments.mx_iugr-newedited.ppt
vdocuments.mx_iugr-newedited.ppt
 
IUGR.pptx
IUGR.pptxIUGR.pptx
IUGR.pptx
 
Iugr
IugrIugr
Iugr
 
Radiology 5th year, 8th & 9th lectures (Dr. Nasrin Alatrushi)
Radiology 5th year, 8th & 9th lectures (Dr. Nasrin Alatrushi)Radiology 5th year, 8th & 9th lectures (Dr. Nasrin Alatrushi)
Radiology 5th year, 8th & 9th lectures (Dr. Nasrin Alatrushi)
 
Zoltan Veresh - Intrauterine growth retardation
Zoltan Veresh - Intrauterine growth retardationZoltan Veresh - Intrauterine growth retardation
Zoltan Veresh - Intrauterine growth retardation
 
Approach to Intrauterine growth restriction
Approach to Intrauterine growth restrictionApproach to Intrauterine growth restriction
Approach to Intrauterine growth restriction
 
Obesity: A Pediatric Epidemic
Obesity: A Pediatric EpidemicObesity: A Pediatric Epidemic
Obesity: A Pediatric Epidemic
 
Macrosomia and iugr with case study for undergraduare
Macrosomia and iugr with case study for undergraduareMacrosomia and iugr with case study for undergraduare
Macrosomia and iugr with case study for undergraduare
 
Module 4 Paediatric Nutrition.pptx
Module 4 Paediatric Nutrition.pptxModule 4 Paediatric Nutrition.pptx
Module 4 Paediatric Nutrition.pptx
 

More from KaranSingh321255

multiple pregnancy its sign symptoms and management.pdf
multiple pregnancy its sign symptoms and management.pdfmultiple pregnancy its sign symptoms and management.pdf
multiple pregnancy its sign symptoms and management.pdfKaranSingh321255
 
Abnormal puerperium and its management.pdf
Abnormal puerperium and its management.pdfAbnormal puerperium and its management.pdf
Abnormal puerperium and its management.pdfKaranSingh321255
 
ABORTION and its types and management.docx
ABORTION and its types and management.docxABORTION and its types and management.docx
ABORTION and its types and management.docxKaranSingh321255
 
STP ON NEUROLOGICAL ASSESSMENT (1).pdf
STP ON NEUROLOGICAL ASSESSMENT   (1).pdfSTP ON NEUROLOGICAL ASSESSMENT   (1).pdf
STP ON NEUROLOGICAL ASSESSMENT (1).pdfKaranSingh321255
 
FACTORS AFFECTING FACULTY STAFF RS.ppt
FACTORS AFFECTING FACULTY STAFF   RS.pptFACTORS AFFECTING FACULTY STAFF   RS.ppt
FACTORS AFFECTING FACULTY STAFF RS.pptKaranSingh321255
 
DEVELOPMENT AND MAINTENANCE OF STANDARDS ,ACCREDITATION (2).pptx
DEVELOPMENT AND MAINTENANCE OF STANDARDS ,ACCREDITATION (2).pptxDEVELOPMENT AND MAINTENANCE OF STANDARDS ,ACCREDITATION (2).pptx
DEVELOPMENT AND MAINTENANCE OF STANDARDS ,ACCREDITATION (2).pptxKaranSingh321255
 
characteristics and problems of counselling 2.pptx
characteristics and problems of counselling 2.pptxcharacteristics and problems of counselling 2.pptx
characteristics and problems of counselling 2.pptxKaranSingh321255
 
psychological disorders during puerperium.pptx
psychological disorders during puerperium.pptxpsychological disorders during puerperium.pptx
psychological disorders during puerperium.pptxKaranSingh321255
 
Presentation__eclampsia.pptx
Presentation__eclampsia.pptxPresentation__eclampsia.pptx
Presentation__eclampsia.pptxKaranSingh321255
 
NCP 2 Pregnancy with IUGR.docx
NCP 2 Pregnancy with IUGR.docxNCP 2 Pregnancy with IUGR.docx
NCP 2 Pregnancy with IUGR.docxKaranSingh321255
 
diagnosis teaching on power point.pptx
diagnosis teaching on power point.pptxdiagnosis teaching on power point.pptx
diagnosis teaching on power point.pptxKaranSingh321255
 
MINOR DISORDERS IN PREGNANCY.docx
MINOR DISORDERS IN PREGNANCY.docxMINOR DISORDERS IN PREGNANCY.docx
MINOR DISORDERS IN PREGNANCY.docxKaranSingh321255
 

More from KaranSingh321255 (18)

multiple pregnancy its sign symptoms and management.pdf
multiple pregnancy its sign symptoms and management.pdfmultiple pregnancy its sign symptoms and management.pdf
multiple pregnancy its sign symptoms and management.pdf
 
Abnormal puerperium and its management.pdf
Abnormal puerperium and its management.pdfAbnormal puerperium and its management.pdf
Abnormal puerperium and its management.pdf
 
ABORTION and its types and management.docx
ABORTION and its types and management.docxABORTION and its types and management.docx
ABORTION and its types and management.docx
 
STP ON NEUROLOGICAL ASSESSMENT (1).pdf
STP ON NEUROLOGICAL ASSESSMENT   (1).pdfSTP ON NEUROLOGICAL ASSESSMENT   (1).pdf
STP ON NEUROLOGICAL ASSESSMENT (1).pdf
 
oxytocin1.pptx
oxytocin1.pptxoxytocin1.pptx
oxytocin1.pptx
 
post natal exercises.ppsx
post natal exercises.ppsxpost natal exercises.ppsx
post natal exercises.ppsx
 
abortion ...pptx
abortion ...pptxabortion ...pptx
abortion ...pptx
 
FACTORS AFFECTING FACULTY STAFF RS.ppt
FACTORS AFFECTING FACULTY STAFF   RS.pptFACTORS AFFECTING FACULTY STAFF   RS.ppt
FACTORS AFFECTING FACULTY STAFF RS.ppt
 
DEVELOPMENT AND MAINTENANCE OF STANDARDS ,ACCREDITATION (2).pptx
DEVELOPMENT AND MAINTENANCE OF STANDARDS ,ACCREDITATION (2).pptxDEVELOPMENT AND MAINTENANCE OF STANDARDS ,ACCREDITATION (2).pptx
DEVELOPMENT AND MAINTENANCE OF STANDARDS ,ACCREDITATION (2).pptx
 
characteristics and problems of counselling 2.pptx
characteristics and problems of counselling 2.pptxcharacteristics and problems of counselling 2.pptx
characteristics and problems of counselling 2.pptx
 
health&welfare.pptx
health&welfare.pptxhealth&welfare.pptx
health&welfare.pptx
 
STDs.pptx
STDs.pptxSTDs.pptx
STDs.pptx
 
psychological disorders during puerperium.pptx
psychological disorders during puerperium.pptxpsychological disorders during puerperium.pptx
psychological disorders during puerperium.pptx
 
hiv in pregnancy.pptx
hiv in pregnancy.pptxhiv in pregnancy.pptx
hiv in pregnancy.pptx
 
Presentation__eclampsia.pptx
Presentation__eclampsia.pptxPresentation__eclampsia.pptx
Presentation__eclampsia.pptx
 
NCP 2 Pregnancy with IUGR.docx
NCP 2 Pregnancy with IUGR.docxNCP 2 Pregnancy with IUGR.docx
NCP 2 Pregnancy with IUGR.docx
 
diagnosis teaching on power point.pptx
diagnosis teaching on power point.pptxdiagnosis teaching on power point.pptx
diagnosis teaching on power point.pptx
 
MINOR DISORDERS IN PREGNANCY.docx
MINOR DISORDERS IN PREGNANCY.docxMINOR DISORDERS IN PREGNANCY.docx
MINOR DISORDERS IN PREGNANCY.docx
 

Recently uploaded

April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 

Recently uploaded (20)

April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 

IUGR-Intrauterine Growth Retardation.ppt

  • 2. DEFINITIONS: a) Low birth weight (LBW) b) Very low birth weight (VLBW) c) Extremely low birth weight (ELBW) d) Premature e) Small for Gestational Age (SGA) f) Large for Gestational Age (AGA) g) Intrauterine Growth Retardation (IUGR) SGA = IUGR = SFD
  • 3. Incidence of SGA: By definition, babies with BW < 10th centile on growth curves are SGA. Therefore, 10% of babies are SGA. However, not as simple as this.
  • 4. 1. Sex: Male infants are 150 grams heavier and o.0 cm. longer than female infants. 2. Parity: First born infants tend to be smaller than infants born subsequently; this effect dissipates after the third birth. 3. Racial and ethnic groups and nationalities have differing normal birth weights.
  • 5. 4. Altitude: In USA for example, growth curves based on the Denver population located approximately 5000 feet above sea level tend to underestimate infants' weights after 32 weeks' gestation. 5. Maternal size: direct association between maternal height and weight and the size of the fetus is well established. Birth weight variation of 750 g between infants born to mothers of 170 cm in height and 75 kg weight when compared with infants born to mothers 150 cm tall and weighing 40 kg has been described.
  • 6. 6. Number of fetuses: mean birth weight decreases with the number of fetuses. ? Need for different growth curves to take the above into account.
  • 7.
  • 8.
  • 9.
  • 10. The overall perinatal mortality in IUGR infants is increased eight- to ten-fold that of AGA infants. Higher risk of developmental problems in SGA infants.
  • 11. Fetal growth occurs in 3 phases. 1. 4-20 weeks' gestation – rapid cellular development with mitosis 2. 20-28 weeks – increase in cellular size combined with ongoing mitosis.
  • 12. 3. 28-40 weeks – cells rapidly increasing in size, with peak at 33 weeks. In addition, rapid accumulation of fat, muscle and connective tissue occurs.
  • 13.
  • 14. • Growth inhibition during stage II and III will cause a decrease of cell size and fetal weight with less effect on total cell number and fetal length and head circumference, causing asymmetric IUGR.
  • 15. Conditions associated with symmetric IUGR: • Genetic - constitutional, chromosomal and single gene defects, and deletion disorders and inborn errors of metabolism. • Congenital anomalies, • Intrauterine infections • Others: substance abuse, cigarette smoking and therapeutic irradiation.
  • 16. Conditions associated with asymmetric IUGR: Uteroplacental insufficiency - chronic hypertension, - preeclampsia, - placental infarcts - abruptio placenta - velamentous insertion of the umbilical cord and circumvallate placenta
  • 17. Maternal illnesses - chronic renal disease, - cyanotic heart disease, - hemoglobinopathies - substance abuse and cigarette smoking. Other factors - multiple gestation - altitude
  • 18. • Under conditions of stress (eg. Hypoxia) – fetus mounts response with increased Adr and NorAdr (found in amniotic fluid) – leads to anti-insulin effect. • In addition, this results in loss of fat, muscle and glycogen with changes in blood flow distribution to ‘vital organs’ (brain, heart and adrenal) – asymmetric.
  • 19. Smoking, substance abuse and SGA. - The mean birth weight is reduced by 175- 200 g in infants born to cigarette smokers - Cotinine decreases uteroplacental blood flow in a dose-related way by stimulating sympathetic neurons. - Carboxyhemoglobin levels are elevated in mothers who smoke and in their fetuses, and the avidity of fetal hemoglobin to carbon monoxide may exacerbate fetal hypoxia.
  • 20. - Nicotine has a demonstrated teratogenic effect in animals. - Marijuana, cocaine, heroin, amphetamines and alcohol can all cause IUGR, with the head circumference affected in many studies, suggesting a symmetrical form of growth retardation and an insult during the cell mitotic phase in early pregnancy.
  • 21. Prenatal Diagnosis: 1. Maternal history: e.g. pregnancy- induced-hypertension. 2. Maternal examination - measurement of fundal height is an excellent screening tool for IUGR. 95% sensitivity. - If fundal height is 4 cm less than expected - ?SGA. Fundal height in cms should equal gestation at 20 to 25 weeks.
  • 22. 3. Fetal ultrasound: BPD and AC measured. - BPD (biparietal diam) 43-100% accurate but inaccuracy due to head-sparing in asymmetric IUGR. - AC (Abdominal circumference better sensitivity than that of cephalometry for IUGR detection. - HC/AC (Head circumference/abdominal circumference ratio) is an important measurement for detection of asymmetric IUGR infants.
  • 23. - Ratio of femoral length to abdominal circumference (FL/AC) provides also an accurate prediction of IUGR.
  • 24. 4. Amniotic fluid volume: oligohydramnios due to decreased renal blood flow and urine output. 5. Blood flow measurements: by Doppler flow studies, fetal and uterine blood flow can be measured and therefore uteroplacental circulation dysfunctions can be assessed.
  • 25. 6. Biochemical data: a. Estriol: low 24 hours urinary estriol excretion is associated with 21% of IUGR infants. b. Human placental lactogen (HPL).
  • 26. Prenatal Management - Symmetric IUGR – need to consider amniocentesis and TORCH analysis, along with Maternal TORCH antibody titres. - Also need to look at Maternal Health – e.g. illness such as chronic renal disease need to be considered. This includes discouraging tobacco use, and substance abuse as well as regular checks through pregnancy
  • 27. - Ongoing close observations, with U/S (including doppler flows) and CTG’s. - Early delivery has to be considered based upon the relative chance of fetal morbidity and mortality in-utero to the chance of morbidity and mortality of prematurity. Can often be a difficult choice.
  • 28. Postnatal Management of SGA baby: These babies handle stress of birth and post-natal life poorly. • Greater risk of stillbirth (4x) • Greater risk of asphyxia (2x) • Likely to have lower APGAR scores • Higher incidence of meconium at delivery • Risk of hypoglycaemia • Risk of hypocalcaemia and hypomagnesaemia • Risk of hypothermia * Note, risk of lung disease is less than with AGA babies as long as they get through birth OK.
  • 29. At delivery: - IUGR infants are more prone to hypoxemia during labor and delivery because of uteroplacental insufficiency, and more prone to cord compression due to lack of amniotic fluid and a thin cord.
  • 30. - A neonatal team capable of managing asphyxia and meconium aspiration syndrome should be available at the time of delivery. - Special attention should be addressed to prevention of hypothermia and hypoglycemia.
  • 31. Physical findings: - Obviously, < 10th centile for gestation. - Look at baby carefully – especially if symmetrically growth retarded. - Need to be wary of genetic/infective causes – look for dysmorphic features, for skin rashes (blueberry muffin and patechiae) and for hepatosplenomegaly
  • 32. - wisened old man appearance - lack of subcutaneous fat - skin is dry cracked and peeling (especially palms & soles) - often thin cord due to lack of Wharton’s jelly - may be meconium stained - ruddy appearance due to polycythaemia - may be jittery due to low sugar or calcium - may also be irritable and show signs of asphyxia, including fitting.
  • 33. Attempt to identify the cause of IUGR: Aetiologies: a. Vascular diseases of the mother (hypertension, renal disease, diabetes, etc.) - 35%. b. Chromosomal and other congenital anomalies of the infant - 10%. c. Normal variations (low maternal weight/height, high altitude, multiple gestation) - 10%.
  • 34. d. Congenital infection - 5%. e. Alcohol, smoking, substance abuse, and medications (antimetabolites for cancer therapy, hydantoin and trimethadion for anticonvulsant therapy) - 5%. f. Placenta and cord defects - 2%. g. Uterine abnormalities - 1%. h. Other: Therapeutic radiation, low socioeconomic level and unknown causes - 32%. * Careful history and examination can identify most causations.
  • 35. Management after birth: SGA babies are at risk as noted. Therefore attention to WARM, PINK, SWEET & INFECTION needed. Need to attend to basics of care – in particular: 1. Respiratory care – esp. with meconium 2. Hypoglycaemia due to low sugar reserves and higher energy consumption – esp. with cold stress.
  • 36. 3. Hypothermia due to lack of subcutaneous fat and relatively high S.A to body weight ratio 4. Beware infection – at risk as immune system of babies is immature – being SGA worsens this.
  • 37. 5. Polycythaemia – due to in-utero hypoxia. Can cause venous thrombo-emboli and can also worsen cerebral ischaemia and perpetuate hypoglycaemia. 6. Haemorrhage – can develop due to lack of liver coag factor production, and also may have low platelets if TORCH 7. Management of asphyxia
  • 38. Investigations of SGA baby: Initially, babies need to be examined in a warm environment. True blood glucose should be assessed at ½ to 1 hour of age, and pre-feeds for at least the next 2 feeds. Feeds should be frequent (2-3 hourly initially).
  • 39. If baby jittery, then glucose and calcium and magnesium must be checked. Full blood count - 3 reasons - polycythaemia - platelet count - white cells
  • 40. Other investigations done on merit - chromosomes - TORCH screen - CXR if respiratory distress - Sepsis workup if possibility of infection - - Urine drug screen, etc., if suspect maternal substance abuse - Cranial US – esp. if concerned about in-utero hypoxia
  • 41. Nutrition: - Important to establish nutrition as early as possible but be wary as hypoxia and polycythaemia may have resulted in diminished gut blood flow – risk of NEC. - If delay in establishing enteral feeds, must use TPN. - Weight gain monitoring needed to ensure sufficiency of caloric intake.
  • 42. - It is common that caloric intake in IUGR infants will exceed the usual intake of 100- 120 Kcal/kg/day, and daily weight gain will exceed 25 g/day. - Neurologic prognosis may relate directly to restoring good nutrition. Poor subsequent head growth bodes poorly for intellectual development.
  • 43. DON’T FORGET THE PARENTS!!!  Parental counselling about diagnosis, risk for physical and developmental sequelae, and risk of IUGR in a subsequent pregnancy, should be provided
  • 44. Outcome for SGA babies: Increased mortality and morbidity as noted. Long term outlook: Neurological. - IUGR infants have an increased risk of long-term neurologic and behavioral handicaps. Infants with ultrasonographic evidence of delayed head growth before the third trimester also have delayed neurologic and intellectual development.
  • 45. - If congenital anomalies and clinically detected prenatal infections are excluded, studies show normal IQ/DQ in most SGA infants. - Preterm IUGR infants have similar outcomes at 18-24 months of age, compared to AGA preterm infants. - Severe malnutrition in utero can decrease the number of brain cells. Normally in the first 2 years of life there occurs a "spurt in brain
  • 46. - Overall, IUGR infants have an increased incidence of lower intelligence, learning and behavioral disorders and neurologic handicaps. - The long-term neurologic outcome in SGA infants is related to the type of SGA, severity and concomitant asphyxial insult. - Future handicap is dependent also on the existence of perinatal complications such as asphyxia, meconium aspiration syndrome, hypothermia, hypoglycemia and polycythemia.
  • 47. Growth. - Asymmetric IUGR infants have better growth potential than symmetric IUGR infants who typically have suffered a genetic, infectious or teratogenic insult early in life. - Asymmetric SGA infants capable of achieving normal weight and proportions within 6-12 months of birth. - Symmetric SGA infants born often remain shorter, lighter and have a smaller head circumference throughout life.
  • 48. Other. - Delayed eruption of teeth and enamel hypoplasia. - Increased incidence of postnatal infections possibly due to delayed humoral and cellular immunity found . - Risk of SIDS considerably greater (30% of SIDS cases occur in SGA infants) – reasons behind SGA may account for this however.